Navigation Links
Macrocyclics introduces new products
Date:1/10/2014

DALLAS, Jan. 10, 2014 /PRNewswire/ -- Macrocyclics, Inc. (an AREVA Med company) announced today the introduction of four new products that will expand PET imaging applications with copper-64 and gallium-68 using NOTA-based chelating platforms. In addition, a new serotonin-based DOTA conjugate offers the potential to image serotoninergic neurotransmission using a radioisotope or with gadolinium by magnetic resonance imaging (MRI).

(Logo: http://photos.prnewswire.com/prnh/20130523/DA20136LOGO)

Please visit www.macrocyclics.com for detailed information.

MORE ABOUT MACROCYCLICS  
Macrocyclics is the global leader in high performance chelating agent technologies for medicine since 1995.  Our team at Macrocyclics is dedicated to providing clients with both established and innovative chelating agents and services to meet the challenges of molecular imaging and nuclear medicine.  www.macrocyclics.com

MORE ABOUT AREVA MED  
AREVA Med is an AREVA subsidiary specializing in the development of innovative therapies to fight cancer. AREVA Med has developed new processes for producing high purity lead-212 (²¹²Pb), a rare metal that is currently at the heart of promising nuclear medicine research.  In 2011, AREVA Med acquired Macrocyclics, the global leader in high performance chelating agent technology.  AREVA Med is also associated with world-class scientific partners, such as the National Cancer Institute (NCI), the University of Alabama at Birmingham (UAB), and the French National Institute of Health and Medical Research (Inserm). In 2012, AREVA Med and Roche entered a strategic alliance to create novel advanced alpha radioimmunotherapy treatments to target and kill certain very aggressive types of cancer cells.  For more information: http://arevamed.areva.com/ or www.targetedtrials.com.

Macrocyclics
Garry Kiefer
T: +1 972 250 2248
F: +1 972 250 2245
info@macrocyclics.com

AREVA Med
Alison Tise
T: +1 301 841 1673
F: +1 434 382 4250
alison.tise@areva.com

 


'/>"/>
SOURCE Macrocyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
2. Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
3. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
4. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
5. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
6. IDEV Technologies Introduces SurePath™ Guidewires
7. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
8. HealthONE® Introduces the Colorado Center for Robotic Surgery(SM)
9. PeriGen, Inc. Introduces New, Advanced Perinatal System at National Perinatal Nursing Convention
10. PharmaNet/i3 Introduces PharmaNet/i3 Strategic Resourcing
11. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... Transparency Market Research states that the ...  held a huge share of 43% in 2015. Apple Inc., ... the overall market, grabbing the undivided attention of buyers with ... and strong product portfolio is expected to keep these companies ... ...
(Date:1/16/2017)... TORONTO , Jan. 16, 2017  Today, Analytics ... cost-effective medical devices, announced its expansion into JLABS @ ... Johnson Innovation,s life science incubators. As a resident in ... of cardiovascular medical device development and commercialization expertise. ... a life science innovation center that provides a flexible ...
(Date:1/15/2017)... January 16, 2017 Der Vorstand ... für die Regeneration des menschlichen Gewebes, gibt die Ernennung ... sofortiger Wirkung bekannt. ... Bill Allan ist ... bekleidete eine Reihe von Geschäftsführer- und anderen Führungspositionen bei ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... 2017 , ... To provide comfort and fuel during the ... category, announces a hearty and wholesome Winter Menu. Starting today, guests can enjoy ... Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & Sausage Soup, and ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF ... in Las Vegas, Booth #2809. The SHOT Show is the shooting, hunting and ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... announced the addition of Victor Giamos, MD to their medical staff, according to ... Partner at North Shore Eye Care, a division of SightMD. Dr. Giamos will ...
(Date:1/16/2017)... ... January 16, 2017 , ... St. Louisans are well-aware of the following facts at present:, ... year’s influenza shot seems to be having no effect on keeping this particularly bad strain ... the people around are coughing, sneezing, or sniffling , These facts are ...
(Date:1/16/2017)... ... 2017 , ... One thing common to all types of cancer is that ... well. The money spent screening for and treating cancer in the United States is ... cancer more than in any other country that has an advanced healthcare system, sometimes ...
Breaking Medicine News(10 mins):